If you are prescribed brand-name semaglutide and find that it is not suitable for you, talk to your healthcare provider about other GLP-1s such as tirzepatide (Zepbound) or liraglutide (Saxenda) that may benefit you
Depending on findings, referral to a neurologist or diabetologist may be appropriate
doi: 10.3389/fmolb.2022.1016090 Received 18 August 2022 Accepted 15 September 2022 Published 29 September 2022 Volume 9 - 2022 Edited by Ye Sun, Boston Children's Hospital, Harvard Medical School, United States Reviewed by Xudong Wang, Massachusetts General Hospital, Harvard Medical School, United States Xiujuan Shi, Tongji University, China Updates Copyright 2022 Ma, Yang, Zuo and Huang
David, you mentioned there's research being done to figure out it might reduce heart attacks meaningfully, strokes, and liver and kidney disease
Hence, understanding these mechanisms is essential for developing targeted dietary interventions to enhance glycaemic regulation and overall metabolic health in individuals with T2D